Total Payments
$790,303
2024 Payments
$129,632
Companies
51
Transactions
1,525
Medicare Patients
17,568
Medicare Billing
$2.6M
Payment Breakdown by Category
Other$643,964 (81.5%)
Travel$66,980 (8.5%)
Consulting$49,594 (6.3%)
Food & Beverage$29,292 (3.7%)
Education$472.57 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $632,539 | 304 | 80.0% |
| Travel and Lodging | $66,980 | 335 | 8.5% |
| Consulting Fee | $49,594 | 46 | 6.3% |
| Food and Beverage | $29,292 | 819 | 3.7% |
| Compensation for serving as faculty or as a speaker for a medical education program | $8,400 | 5 | 1.1% |
| Honoraria | $2,500 | 1 | 0.3% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $525.00 | 1 | 0.1% |
| Education | $472.57 | 14 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $505,819 | 642 | $0 (2024) |
| Lilly USA, LLC | $145,041 | 253 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $64,195 | 88 | $0 (2024) |
| Echosens North America, Inc. | $45,427 | 45 | $0 (2024) |
| Abbott Laboratories | $17,283 | 36 | $0 (2024) |
| Quidel Corporation | $2,500 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $1,154 | 63 | $0 (2023) |
| Amgen Inc. | $1,009 | 44 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $993.42 | 39 | $0 (2024) |
| ABBVIE INC. | $875.13 | 47 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $129,632 | 219 | Lilly USA, LLC ($80,330) |
| 2023 | $107,540 | 198 | Lilly USA, LLC ($63,900) |
| 2022 | $117,021 | 218 | Novo Nordisk Inc ($65,077) |
| 2021 | $101,529 | 186 | Novo Nordisk Inc ($70,904) |
| 2020 | $69,616 | 139 | Novo Nordisk Inc ($67,819) |
| 2019 | $85,592 | 168 | Novo Nordisk Inc ($83,779) |
| 2018 | $95,265 | 184 | Novo Nordisk Inc ($86,126) |
| 2017 | $84,108 | 213 | Novo Nordisk Inc ($82,075) |
All Payment Transactions
1,525 individual payment records from CMS Open Payments — Page 1 of 61
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/10/2024 | Echosens North America, Inc. | FibroScan (Device) | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| Category: Elastography | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/06/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| 12/05/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $37.40 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Endocrinology | ||||||
| 11/29/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: LIVER DISEASE | ||||||
| 11/21/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| 11/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| 11/19/2024 | Radius Health, Inc. | — | Food and Beverage | In-kind items and services | $24.13 | General |
| 11/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Obesity | ||||||
| 11/07/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Bone Health | ||||||
| 11/07/2024 | Amgen Inc. | EVENITY (Biological) | Education | In-kind items and services | $17.69 | General |
| Category: Bone Health | ||||||
| 11/05/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $26.94 | General |
| 10/23/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| 10/15/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 10/10/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,281.25 | General |
| 10/10/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $871.12 | General |
| 10/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $72.78 | General |
| 10/10/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 3,991 | 21,230 | $1.9M | $657,673 |
| 2022 | 45 | 4,550 | 20,717 | $1.9M | $674,348 |
| 2021 | 51 | 4,865 | 22,758 | $2.1M | $710,413 |
| 2020 | 38 | 4,162 | 17,734 | $1.6M | $516,699 |
Total Patients
17,568
Total Services
82,439
Medicare Billing
$2.6M
Procedure Codes
169
All Medicare Procedures & Services
169 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 133 | 13,560 | $675,000 | $248,587 | 36.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 389 | 1,153 | $403,550 | $125,716 | 31.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 94 | 707 | $106,050 | $39,754 | 37.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 221 | 337 | $92,675 | $26,715 | 28.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 111 | 120 | $60,000 | $21,408 | 35.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 134 | 139 | $50,325 | $21,086 | 41.9% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 79 | 458 | $68,550 | $19,717 | 28.8% |
| 76981 | Ultrasound scan of organ tissue for measuring elasticity | Office | 2023 | 163 | 190 | $42,650 | $18,671 | 43.8% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 142 | 156 | $50,700 | $18,130 | 35.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 169 | 267 | $53,400 | $13,066 | 24.5% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 140 | 154 | $38,500 | $12,591 | 32.7% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 140 | 154 | $38,500 | $11,664 | 30.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 160 | 160 | $12,000 | $11,509 | 95.9% |
| 77085 | Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | Office | 2023 | 180 | 180 | $58,240 | $11,019 | 18.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 411 | 1,156 | $15,885 | $9,710 | 61.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 172 | 172 | $8,600 | $6,189 | 72.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 35 | 35 | $17,500 | $5,090 | 29.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 219 | 279 | $25,110 | $3,667 | 14.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 146 | 280 | $14,000 | $3,631 | 25.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 14 | $4,900 | $3,583 | 73.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $9,200 | $3,094 | 33.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 67 | 98 | $8,330 | $3,005 | 36.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 38 | 47 | $7,050 | $2,714 | 38.5% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 163 | 515 | $5,150 | $1,983 | 38.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 33 | 34 | $6,800 | $1,940 | 28.5% |
About Dr. Martin Grajower, MD
Dr. Martin Grajower, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538245824.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Martin Grajower, MD has received a total of $790,303 in payments from pharmaceutical and medical device companies, with $129,632 received in 2024. These payments were reported across 1,525 transactions from 51 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($632,539).
As a Medicare-enrolled provider, Grajower has provided services to 17,568 Medicare beneficiaries, totaling 82,439 services with total Medicare billing of $2.6M. Data is available for 4 years (2020–2023), covering 169 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Bronx, NY
- Active Since 10/28/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1538245824
Products in Payments
- Ozempic (Drug) $178,924
- MOUNJARO (Drug) $135,607
- Victoza (Drug) $87,354
- RYBELSUS (Drug) $86,406
- Kerendia (Drug) $64,195
- Tresiba (Drug) $48,762
- FibroScan (Device) $45,427
- Rybelsus (Drug) $29,457
- FreeStyle Libre Pro (Device) $16,811
- Xultophy 100/3.6 (Drug) $8,776
- JARDIANCE (Drug) $1,232
- FARXIGA (Drug) $874.01
- EVENITY (Biological) $751.87
- UNITHROID (Drug) $681.00
- Korlym (Drug) $522.42
- SYNTHROID (Drug) $462.21
- TRULICITY (Drug) $352.67
- Synthroid (Drug) $337.42
- CYCLOSET (Drug) $303.25
- SOLIQUA 100/33 (Biological) $292.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Bronx
Dr. John Eng, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $7.2M
Endocrinology, Diabetes & Metabolism $7.2M
Joel Zonszein, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $260,019
Endocrinology, Diabetes & Metabolism $260,019
Meyer Halberstam, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $236,748
Endocrinology, Diabetes & Metabolism $236,748
Dr. Rodolfo Guzman, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $18,008
Endocrinology, Diabetes & Metabolism $18,008
Dr. Carlos Driggs, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $7,350
Endocrinology, Diabetes & Metabolism $7,350
Jessica Starr, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $5,576
Endocrinology, Diabetes & Metabolism $5,576